BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stange J, Hassanein TI, Mehta R, Mitzner SR, Bartlett RH. The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers. Artif Organs. 2002;26:103-110. [PMID: 11879237 DOI: 10.1046/j.1525-1594.2002.06822.x] [Cited by in Crossref: 154] [Cited by in F6Publishing: 134] [Article Influence: 8.1] [Reference Citation Analysis]
Number Citing Articles
1 Bergasa NV. Medical palliation of the jaundiced patient with pruritus. Gastroenterol Clin North Am. 2006;35:113-123. [PMID: 16530114 DOI: 10.1016/j.gtc.2005.12.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
2 Marrero J, Martinez FJ, Hyzy R. Advances in Critical Care Hepatology. Am J Respir Crit Care Med 2003;168:1421-6. [DOI: 10.1164/rccm.200303-361up] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
3 Wang Z, Wei H, Jia L, Xu L, Zou C, Xie J. Water-soluble adsorbent β-cyclodextrin-grafted polyethyleneimine for removing bilirubin from plasma. Transfusion and Apheresis Science 2012;47:159-65. [DOI: 10.1016/j.transci.2012.06.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Sen S, Rose C, Ytrebø LM, Davies NA, Nedredal GI, Drevland SS, Kjønnø M, Prinzen FW, Hodges SJ, Deutz NE. Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study. Crit Care Med. 2006;34:158-164. [PMID: 16374170 DOI: 10.1097/01.ccm.0000196203.39832.3c] [Cited by in Crossref: 69] [Cited by in F6Publishing: 15] [Article Influence: 4.6] [Reference Citation Analysis]
5 Tsai M, Chen Y, Wu C, Ho Y, Fang J, Lien J, Yang C, Chu Y, Liu N, Lin C, Chiu C, Chen P. Extracorporal liver support with molecular adsorbents recirculating system in patients with hepatitis B-associated fulminant hepatic failure: MARS IN HBV-ASSOCIATED FULMINANT HEPATIC FAILURE. International Journal of Clinical Practice 2005;59:1289-94. [DOI: 10.1111/j.1742-1241.2005.00604.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
6 Park J, Toner M, Yarmush ML, Tilles AW. Microchannel bioreactors for bioartificial liver support. Microfluid Nanofluid 2006;2:525-35. [DOI: 10.1007/s10404-006-0095-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
7 Campli CD, Gaspari R, Mignani V, Stifano G, Santoliquido A, Verme LZD, Proietti R, Pola P, Silveri NG, Gasbarrini G, Gasbarrini A. Successful MARS Treatment in Severe Cholestatic Patients with Acute on Chronic Liver Failure. Artificial Organs 2003;27:565-9. [DOI: 10.1046/j.1525-1594.2003.07138.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
8 Meijers BKI, Verhamme P, Nevens F, Hoylaerts MF, Bammens B, Wilmer A, Arnout J, Vanrenterghem Y, Evenepoel P. Major Coagulation Disturbances During Fractionated Plasma Separation and Adsorption. Am J Transplant 2007;7:2195-9. [DOI: 10.1111/j.1600-6143.2007.01909.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
9 Mora JM, Olmedo R, Curiel E, Muñoz J, Herrera M, Séller G. [MARS (Molecular Absorbent Recirculating System) as hepatic extracorporeal care in serious acute liver failure of alcoholic etiology]. Med Intensiva. 2006;30:402-406. [PMID: 17129540 DOI: 10.1016/S0210-5691(06)74556-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Covic A, Goldsmith DJA, Gusbeth-tatomir P, Volovat C, Dimitriu AG, Cristogel F, Bizo A. Successful use of Molecular Absorbent Regenerating System (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion: MARS dialysis in mushroom intoxications. Liver International 2003;23:21-7. [DOI: 10.1034/j.1478-3231.23.s.3.9.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
11 Yuan JZ, Ye QF, Zhao LL, Ming YZ, Sun H, Zhu SH, Huang ZF, Wang MM. Preoperative risk factor analysis in orthotopic liver transplant-ation with pretransplant artificial liver support therapy. World J Gastroenterol 2006; 12(31): 5055-5059 [PMID: 16937506 DOI: 10.3748/wjg.v12.i31.5055] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
12 Allen JW, Bhatia SN. Improving the next generation of bioartificial liver devices. Semin Cell Dev Biol. 2002;13:447-454. [PMID: 12468246 DOI: 10.1016/S1084952102001337] [Cited by in Crossref: 56] [Cited by in F6Publishing: 11] [Article Influence: 3.1] [Reference Citation Analysis]
13 Hassanein TI, Schade RR, Hepburn IS. Acute-on-chronic liver failure: extracorporeal liver assist devices. Curr Opin Crit Care. 2011;17:195-203. [PMID: 21346566 DOI: 10.1097/mcc.0b013e328344b3aa] [Cited by in Crossref: 40] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
14 Laleman W, Wilmer A, Evenepoel P, Verslype C, Fevery J, Nevens F. Review article: non-biological liver support in liver failure. Aliment Pharmacol Ther. 2006;23:351-363. [PMID: 16422994 DOI: 10.1111/j.1365-2036.2006.02765.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
15 Soeters PB. Rationale for albumin infusions: . Current Opinion in Clinical Nutrition and Metabolic Care 2009;12:258-64. [DOI: 10.1097/mco.0b013e32832a3e1a] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
16 Lebherz-Eichinger D, Schwarzer R, Motal MC, Klaus DA, Mangold A, Ankersmit HJ, Berlakovich GA, Krenn CG, Roth GA. Liver transplantation reverses hypergammaglobulinemia in patients with chronic hepatic failure. Biochem Med (Zagreb) 2015;25:252-61. [PMID: 26110038 DOI: 10.11613/BM.2015.026] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
17 Rifai K, Tetta C, Ronco C. Liver Support with Fractionated Plasma Separation and Adsorption and Prometheus®. Yearbook of Intensive Care and Emergency Medicine. Berlin: Springer Berlin Heidelberg; 2008. pp. 777-84. [DOI: 10.1007/978-3-540-77290-3_72] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Chawla LS, Georgescu F, Abell B, Seneff MG, Kimmel PL. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin. Am J Kidney Dis 2005;45:e51-6. [PMID: 15754264 DOI: 10.1053/j.ajkd.2004.11.023] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
19 Singh V, Bhalla A, Sharma N, Dheerendra P, Agarwal R, Mahi S. Nasobiliary drainage in acute cholestatic hepatitis with pruritus. Digestive and Liver Disease 2009;41:442-5. [DOI: 10.1016/j.dld.2008.06.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
20 Bergasa NV. An approach to the management of the pruritus of cholestasis. Clinics in Liver Disease 2004;8:55-66. [DOI: 10.1016/s1089-3261(03)00128-4] [Cited by in Crossref: 9] [Article Influence: 0.5] [Reference Citation Analysis]
21 Søreide JA, Deshpande R. Post hepatectomy liver failure (PHLF) - Recent advances in prevention and clinical management. Eur J Surg Oncol 2021;47:216-24. [PMID: 32943278 DOI: 10.1016/j.ejso.2020.09.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
22 Guo LM, Liu JY, Xu DZ, Li BS, Han H, Wang LH, Zhang WY, Lu LH, Guo X, Sun FX. Application of Molecular Adsorbents Recirculating System to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome. Liver Int. 2003;23 Suppl 3:16-20. [PMID: 12950956 DOI: 10.1034/j.1478-3231.23.s.3.7.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 4.2] [Reference Citation Analysis]
23 Bañares R, Catalina MV, Vaquero J. Liver support systems: will they ever reach prime time? Curr Gastroenterol Rep 2013;15:312. [PMID: 23392862 DOI: 10.1007/s11894-013-0312-x] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
24 Sauer IM, Baurmeister U. Cell-Free Artificial Liver Support. Therapher Dial 2006;10:105-7. [DOI: 10.1111/j.1744-9987.2006.00350.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
25 Santoro A, Mancini E, Buttiglieri S, Krause A, Yakubovich M, Tetta C. Extracorporeal support of liver function (II part). Int J Artif Organs 2004;27:176-85. [PMID: 15112883 DOI: 10.1177/039139880402700304] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
26 Vitale G, Gitto S, Vukotic R, Raimondi F, Andreone P. Familial intrahepatic cholestasis: New and wide perspectives. Dig Liver Dis. 2019;51:922-933. [PMID: 31105019 DOI: 10.1016/j.dld.2019.04.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
27 Rifai K, Bahr MJ. Akutes Leberversagen. Internist 2003;44:585-98. [DOI: 10.1007/s00108-003-0914-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
28 Bakos Á, Rikker C, Tóvárosi S, Kárteszi †. The therapeutical efficiency of the newest extracorporal elimination procedure (Prometheus® treatment) in acute liver failure caused by intoxication. Orvosi Hetilap 2007;148:1981-8. [DOI: 10.1556/oh.2007.28171] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
29 Patzer JF 2nd, Safta SA, Miller RH. Slow continuous ultrafiltration with bound solute dialysis. ASAIO J 2006;52:47-58. [PMID: 16436890 DOI: 10.1097/01.mat.0000196524.36394.0d] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
30 Dhawan A. Acute liver failure in childhood. J Gastroenterol Hepatol 2004;19:S382-5. [DOI: 10.1111/j.1440-1746.2004.03707.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
31 Eefsen M, Rasmussen A, Wulf HC, Brock A, Hansen BA. Erythropoietic protoporphyria and pretransplantation treatment with nonbiological liver assist devices. Liver Transpl 2007;13:655-7. [PMID: 17377916 DOI: 10.1002/lt.21049] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
32 Rifai K, Ernst T, Kretschmer U, Haller H, Manns MP, Fliser D. Removal selectivity of Prometheus: A new extracorporeal liver support device. World J Gastroenterol 2006; 12(6): 940-944 [PMID: 16521224 DOI: 10.3748/wjg.v12.i6.940] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
33 Hochleitner B, Hengster P, Duo L, Bucher H, Klima G, Margreiter R. A novel bioartificial liver with culture of porcine hepatocyte aggregates under simulated microgravity. Artif Organs 2005;29:58-66. [PMID: 15644085 DOI: 10.1111/j.1525-1594.2004.29014.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
34 Catalina MV, Barrio J, Anaya F, Salcedo M, Rincón D, Clemente G, Bañares R. Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure. Liver Int 2003;23 Suppl 3:39-43. [PMID: 12950960 DOI: 10.1034/j.1478-3231.23.s.3.10.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
35 Wong F. Drug insight: the role of albumin in the management of chronic liver disease. Nat Clin Pract Gastroenterol Hepatol 2007;4:43-51. [PMID: 17203088 DOI: 10.1038/ncpgasthep0680] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
36 Santoro A, Faenza S, Mancini E, Ferramosca E, Grammatico F, Zucchelli A, Facchini M, Pinna A. Prometheus System: A Technological Support in Liver Failure. Transplantation Proceedings 2006;38:1078-82. [DOI: 10.1016/j.transproceed.2006.02.017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
37 Gerlach JC, Zeilinger K, Patzer Ii JF. Bioartificial liver systems: why, what, whither? Regenerative Medicine 2008;3:575-95. [DOI: 10.2217/17460751.3.4.575] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
38 Rifai K. Extracorporeal albumin dialysis. Hepatology Research 2008;38:S41-5. [DOI: 10.1111/j.1872-034x.2008.00425.x] [Cited by in Crossref: 12] [Article Influence: 0.9] [Reference Citation Analysis]
39 Gerlach JC, Hout M, Gage K, Zeilinger K. Liver Cell-Based Therapy – Bioreactors as Enabling Technology. Principles of Regenerative Medicine. Elsevier; 2008. pp. 1086-105. [DOI: 10.1016/b978-012369410-2.50065-6] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
40 Pless G. Artificial and bioartificial liver support. Organogenesis. 2007;3:20-24. [PMID: 19279696 DOI: 10.4161/org.3.1.3635] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
41 Mela M, Mancuso A, Burroughs AK. Review article: pruritus in cholestatic and other liver diseases. Aliment Pharmacol Ther. 2003;17:857-870. [PMID: 12656688 DOI: 10.1046/j.1365-2036.2003.01458.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 64] [Article Influence: 4.9] [Reference Citation Analysis]
42 Roth GA, Sipos W, Höferl M, Böhmdorfer M, Schmidt EM, Hetz H, Schebesta K, Klaus D, Motal M, Jäger W, Krenn CG. The effect of the molecular adsorbent recirculating system on moxifloxacin and meropenem plasma levels. Acta Anaesthesiol Scand 2013;57:461-7. [PMID: 23237505 DOI: 10.1111/aas.12041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
43 Modi RM, Patel N, Metwally SN, Mumtaz K. Outcomes of liver transplantation in patients with hepatorenal syndrome. World J Hepatol 2016; 8(24): 999-1011 [PMID: 27648152 DOI: 10.4254/wjh.v8.i24.999] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
44 Stefoni S, Colì L, Bolondi L, Donati G, Ruggeri G, Feliciangeli G, Piscaglia F, Silvagni E, Sirri M, Donati G, Baraldi O, Soverini ML, Cianciolo G, Boni P, Patrono D, Ramazzotti E, Motta R, Roda A, Simoni P, Magliulo M, Borgnino LC, Ricci D, Mezzopane D, Cappuccilli ML. Molecular adsorbent recirculating system (MARS) application in liver failure: clinical and hemodepurative results in 22 patients. Int J Artif Organs 2006;29:207-18. [PMID: 16552668 DOI: 10.1177/039139880602900207] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
45 Hofmann AF. Inappropriate ileal conservation of bile acids in cholestatic liver disease: homeostasis gone awry. Gut 2003;52:1239-41. [PMID: 12912852 DOI: 10.1136/gut.52.9.1239] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
46 Kumar P, Charaniya R, Ahuja A, Mittal S, Sahoo R. Benign Recurrent Intrahepatic Cholestasis in a Young Adult. J Clin Diagn Res 2016;10:OD01-2. [PMID: 27504332 DOI: 10.7860/JCDR/2016/18917.7924] [Reference Citation Analysis]
47 Wong LP, Blackley MP, Andreoni KA, Chin H, Falk RJ, Klemmer PJ. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney Int. 2005;68:362-370. [PMID: 15954928 DOI: 10.1111/j.1523-1755.2005.00408.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 65] [Article Influence: 5.8] [Reference Citation Analysis]
48 Bansal S, Dhawan A. Acute liver failure. Indian J Pediatr 2006;73:931-4. [PMID: 17090907 DOI: 10.1007/BF02859289] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
49 Parés A, Cisneros L, Salmerón JM, Caballería L, Mas A, Torras A, Rodés J. Extracorporeal albumin dialysis: a procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol. 2004;99:1105-1110. [PMID: 15180733 DOI: 10.1111/j.1572-0241.2004.30204.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 62] [Article Influence: 4.5] [Reference Citation Analysis]
50 Rifai K, Ernst T, Kretschmer U, Bahr MJ, Schneider A, Hafer C, Haller H, Manns MP, Fliser D. Prometheus® – a new extracorporeal system for the treatment of liver failure☆. Journal of Hepatology 2003;39:984-90. [DOI: 10.1016/s0168-8278(03)00468-9] [Cited by in Crossref: 208] [Cited by in F6Publishing: 22] [Article Influence: 11.6] [Reference Citation Analysis]
51 Bartlett RH. Artificial organs: basic science meets critical care. Journal of the American College of Surgeons 2003;196:171-9. [DOI: 10.1016/s1072-7515(02)01605-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Witzke O, Baumann M, Patschan D, Patschan S, Mitchell A, Treichel U, Gerken G, Philipp T, Kribben A. Which patients benefit from hemodialysis therapy in hepatorenal syndrome? J Gastroenterol Hepatol 2004;19:1369-73. [PMID: 15610310 DOI: 10.1111/j.1440-1746.2004.03471.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
53 Bergasa NV. Pruritus in chronic liver disease: mechanisms and treatment. Curr Gastroenterol Rep 2004;6:10-6. [PMID: 14720448 DOI: 10.1007/s11894-004-0020-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
54 Aladağ M, Gürakar A, Jalil S, Wright H, Alamian S, Rashwan S, Sebastian A, Nour B. A liver transplant center experience with liver dialysis in the management of patients with fulminant hepatic failure: a preliminary report. Transplantation Proceedings 2004;36:203-5. [DOI: 10.1016/j.transproceed.2003.11.055] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
55 van de Kerkhove MP, Hoekstra R, van Gulik TM, Chamuleau RA. Large animal models of fulminant hepatic failure in artificial and bioartificial liver support research. Biomaterials. 2004;25:1613-1625. [PMID: 14697863 DOI: 10.1016/s0142-9612(03)00509-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
56 Sen S, Mookerjee RP, Davies NA, Williams R, Jalan R. Review article: the molecular adsorbents recirculating system (MARS) in liver failure. Aliment Pharmacol Ther. 2002;16 Suppl 5:32-38. [PMID: 12423451 DOI: 10.1046/j.1365-2036.16.s5.5.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
57 Onodera K, Sakata H, Yonekawa M, Kawamura A. Artificial liver support at present and in the future. J Artif Organs. 2006;9:17-28. [PMID: 16614798 DOI: 10.1007/s10047-005-0320-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
58 Stadlbauer V, Krisper P, Beuers U, Haditsch B, Schneditz D, Jung A, Putz-Bankuti C, Holzer H, Trauner M, Stauber RE. Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure. ASAIO J. 2007;53:187-193. [PMID: 17413559 DOI: 10.1097/01.mat.0000249852.71634.6c] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
59 Laleman W, Wilmer A, Evenepoel P, Elst IV, Zeegers M, Zaman Z, Verslype C, Fevery J, Nevens F. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care. 2006;10:R108. [PMID: 16859530 DOI: 10.1186/cc4455] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Hetz H, Faybik P, Berlakovich G, Baker A, Bacher A, Burghuber C, Sandner SE, Steltzer H, Krenn CG. Molecular adsorbent recirculating system in patients with early allograft dysfunction after liver transplantation: a pilot study. Liver Transpl 2006;12:1357-64. [PMID: 16741899 DOI: 10.1002/lt.20804] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
61 Unger K, Ditz R, Machtejevas E, Skudas R. Liquid Chromatography-Its Development and Key Role in Life Science Applications. Angew Chem Int Ed 2010;49:2300-12. [DOI: 10.1002/anie.200906976] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
62 Nussler AK, Zeilinger K, Schyschka L, Ehnert S, Gerlach JC, Yan X, Lee SM, Ilowski M, Thasler WE, Weiss TS. Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues. J Mater Sci Mater Med 2011;22:1087-99. [PMID: 21461918 DOI: 10.1007/s10856-011-4306-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
63 Dhawan A, Cheeseman P, Mieli-Vergani G. Approaches to acute liver failure in children. Pediatr Transplant 2004;8:584-8. [PMID: 15598330 DOI: 10.1111/j.1399-3046.2004.00292.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 52] [Article Influence: 4.3] [Reference Citation Analysis]
64 van de Kerkhove M, Chamuleau RAFM, van Gulik TM. Clinical application of bioartificial liver support systems. In: Jones EA, Meijer AJ, Chamuleau RAFM, editors. Encephalopathy and Nitrogen Metabolism in Liver Failure. Dordrecht: Springer Netherlands; 2003. pp. 389-406. [DOI: 10.1007/978-94-010-0159-5_38] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
65 Nishimura A, Umehara Y, Umehara M, Hakamada K, Narumi S, Toyoki Y, Yoshihara S, Sasaki M. Plasma Exchange-based Plasma Recycling Dialysis System as a Potential Platform for Artificial Liver Support. Artificial Organs 2006;30:629-33. [DOI: 10.1111/j.1525-1594.2006.00273.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
66 Gaspari R, Avolio A, Zileri Dal Verme L, Agnes S, Proietti R, Castagneto M, Gasbarrini A. Molecular Adsorbent Recirculating System in Liver Transplantation: Safety and Efficacy. Transplantation Proceedings 2006;38:3544-51. [DOI: 10.1016/j.transproceed.2006.10.032] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
67 Shinohara H, Shimada M, Ikemoto T, Morine Y, Imura S, Fujii M, Imaizumi T, Murayama M, Aiba Y. New type of artificial liver support system (ALSS) using the photocatalytic effect of titanium oxide. Dig Dis Sci 2007;52:2271-5. [PMID: 17431780 DOI: 10.1007/s10620-006-9701-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
68 Radha Krishna Y, Saraswat VA, Das K, Himanshu G, Yachha SK, Aggarwal R, Choudhuri G. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis. Liver Int. 2009;29:392-398. [PMID: 19267864 DOI: 10.1111/j.1478-3231.2008.01887.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 6.9] [Reference Citation Analysis]
69 Stiffel M, Dammeier N, Schmidt S, Szyszkowitz T, Sikole M, Sieveking C, Stange J. 24-Hour Performance of Albumin Dialysis Assessed by a New Two-Compartment In Vitro Model: 24-Hour Model of Albumin Dialysis. Ther Apher Dial 2014;18:79-86. [DOI: 10.1111/1744-9987.12025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
70 Hassanein TI, Tofteng F, Brown RS Jr, McGuire B, Lynch P, Mehta R, Larsen FS, Gornbein J, Stange J, Blei AT. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 2007;46:1853-62. [PMID: 17975845 DOI: 10.1002/hep.21930] [Cited by in Crossref: 278] [Cited by in F6Publishing: 207] [Article Influence: 21.4] [Reference Citation Analysis]
71 Neuberger J. Developments in liver transplantation. Gut 2004;53:759-68. [PMID: 15082598 DOI: 10.1136/gut.2003.024927] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
72 Dhawan A, Mieli-vergani G. Acute liver failure in neonates. Early Human Development 2005;81:1005-10. [DOI: 10.1016/j.earlhumdev.2005.10.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
73 Javouhey E, Ranchin B, Lachaux A, Boillot O, Martin X, Floret D, Cochat P. Long-lasting extracorporeal albumin dialysis in a child with end-stage renal disease and severe cholestasis. Pediatric Transplantation 2009;13:235-9. [DOI: 10.1111/j.1399-3046.2008.00946.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
74 Roth GA, Lubsczyk BA, Pilz J, Faybik P, Hetz H, Krenn CG. Nucleosome serum levels in acute hepatic failure and MARS treatment. Transplant Proc 2009;41:4207-10. [PMID: 20005370 DOI: 10.1016/j.transproceed.2009.08.073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
75 Gan JH, Zhou XQ, Qin AL, Luo EP, Zhao WF, Yu H, Xu J. Hybrid artificial liver support system for treatment of severe liver failure. World J Gastroenterol 2005; 11(6): 890-894 [PMID: 15682488 DOI: 10.3748/wjg.v11.i6.890] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
76 Patzer J. Principles of bound solute dialysis. Ther Apher Dial 2006;10:118-24. [PMID: 16684212 DOI: 10.1111/j.1744-9987.2006.00352.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
77 Unger K, Ditz R, Machtejevas E, Skudas R. Flüssigkeitschromatographie - ihre Entwicklung und Bedeutung für die Lebenswissenschaften. Angew Chem 2010;122:2350-63. [DOI: 10.1002/ange.200906976] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
78 Fiaccadori E, Pistolesi V, Mariano F, Mancini E, Canepari G, Inguaggiato P, Pozzato M, Morabito S. Regional citrate anticoagulation for renal replacement therapies in patients with acute kidney injury: a position statement of the Work Group “Renal Replacement Therapies in Critically Ill Patients” of the Italian Society of Nephrology. J Nephrol 2015;28:151-64. [DOI: 10.1007/s40620-014-0160-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
79 Moore JK, Love E, Craig DG, Hayes PC, Simpson KJ. Acute kidney injury in acute liver failure: a review. Expert Rev Gastroenterol Hepatol 2013;7:701-12. [PMID: 24134153 DOI: 10.1586/17474124.2013.837264] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
80 Vanholder R, del Canizo JF, Sauer IM, Stegmayr B. The European Artificial Organ Scene: Present Status. Artificial Organs 2005;29:498-506. [DOI: 10.1111/j.1525-1594.2005.29079.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
81 Hofmann AF. Rifampicin and treatment of cholestatic pruritus. Gut 2002;51:756-7. [PMID: 12377823 DOI: 10.1136/gut.51.5.756] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
82 Stadlbauer V, Krisper P, Aigner R, Haditsch B, Jung A, Lackner C, Stauber RE. Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure. Crit Care 2006;10:R169. [PMID: 17156425 DOI: 10.1186/cc5119] [Cited by in Crossref: 91] [Cited by in F6Publishing: 80] [Article Influence: 6.5] [Reference Citation Analysis]
83 Warrillow SJ, Bellomo R. Preventing cerebral oedema in acute liver failure: the case for quadruple-H therapy. Anaesth Intensive Care. 2014;42:78-88. [PMID: 24471667 DOI: 10.1177/0310057x1404200114] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 2.4] [Reference Citation Analysis]
84 Khuroo MS, Khuroo MS, Farahat KL. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis. Liver Transpl. 2004;10:1099-1106. [PMID: 15349999 DOI: 10.1002/lt.20139] [Cited by in Crossref: 130] [Cited by in F6Publishing: 101] [Article Influence: 7.6] [Reference Citation Analysis]
85 O'beirne J, Wendon J. Liver support. Int J Artif Organs 2005;28:477-81. [DOI: 10.1177/039139880502800508] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
86 Rifai K, Hafer C, Rosenau J, Athmann C, Haller H, Peter Manns M, Fliser D. Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus®). Scandinavian Journal of Gastroenterology 2009;41:1212-7. [DOI: 10.1080/00365520600610154] [Cited by in Crossref: 42] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
87 Sen S, Williams R, Jalan R. Emerging indications for albumin dialysis. Am J Gastroenterol. 2005;100:468-475. [PMID: 15667509 DOI: 10.1111/j.1572-0241.2005.40864.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
88 . Abstracts of the European Association of Poisons Centres and Clinical Toxicologists XXV International Congress. Clinical Toxicology 2008;43:387-538. [DOI: 10.1080/07313820500207624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
89 Sen S, Jalan R. The role of the Molecular Adsorbents Recirculating System (MARS) in the management of liver failure. Perfusion 2004;19:S43-8. [DOI: 10.1191/0267659104pf716oa] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
90 Oettl K, Stauber RE. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol. 2007;151:580-590. [PMID: 17471184 DOI: 10.1038/sj.bjp.0707251] [Cited by in Crossref: 216] [Cited by in F6Publishing: 192] [Article Influence: 15.4] [Reference Citation Analysis]
91 Roth G, Faybik P, Hetz H, Hacker S, Ankersmit H, Bacher A, Thalhammer T, Krenn C. Pro-inflammatory Interleukin-18 and Caspase-1 serum levels in liver failure are unaffected by MARS treatment. Digestive and Liver Disease 2009;41:417-23. [DOI: 10.1016/j.dld.2008.09.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
92 Organization Committee of 13th Asia-Pacific Congress of Clinical Microbiology and Infection. 13th Asia-Pacific Congress of Clinical Microbiology and Infection Consensus Guidelines for diagnosis and treatment of liver failure. Hepatobiliary Pancreat Dis Int. 2013;12:346-354. [PMID: 23924491 DOI: 10.1016/s1499-3872(13)60055-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
93 Hessel FP. Economic evaluation of the artificial liver support system MARS in patients with acute-on-chronic liver failure. Cost Eff Resour Alloc 2006;4:16. [PMID: 17022815 DOI: 10.1186/1478-7547-4-16] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
94 Montero J, Pozo J, Barrera P, Fraga E, Costán G, Domínguez J, Muntané J, Rodriguez-ariza A, Pleguezuelo M, Rufián S, López-cillero P, de la Mata M. Treatment of Refractory Cholestatic Pruritus With Molecular Adsorbent Recirculating System (MARS). Transplantation Proceedings 2006;38:2511-3. [DOI: 10.1016/j.transproceed.2006.08.052] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
95 Ichai P, Duclos-Vallée JC, Guettier C, Hamida SB, Antonini T, Delvart V, Saliba F, Azoulay D, Castaing D, Samuel D. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl. 2007;13:996-1003. [PMID: 17370335 DOI: 10.1002/lt.21036] [Cited by in Crossref: 160] [Cited by in F6Publishing: 130] [Article Influence: 11.4] [Reference Citation Analysis]
96 Saich R, Selden C, Rees M, Hodgson H. Characterization of pro-apoptotic effect of liver failure plasma on primary human hepatocytes and its modulation by molecular adsorbent recirculation system therapy. Artif Organs 2007;31:732-42. [PMID: 17725701 DOI: 10.1111/j.1525-1594.2007.00447.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
97 Sauer IM, Zeilinger K, Pless G, Kardassis D, Theruvath T, Pascher A, Goetz M, Neuhaus P, Gerlach JC. Extracorporeal liver support based on primary human liver cells and albumin dialysis--treatment of a patient with primary graft non-function. J Hepatol. 2003;39:649-653. [PMID: 12971979 DOI: 10.1016/s0168-8278(03)00348-9] [Cited by in Crossref: 79] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
98 Takahashi K, Umehara Y, Umehara M, Nishimura A, Narumi S, Toyoki Y, Hakamada K, Yoshihara S, Sasaki M. Plasma Exchange-based Plasma Recycling Dialysis System as an Artificial Liver Support. Therapeutic Apheresis and Dialysis 2008;12:264-70. [DOI: 10.1111/j.1744-9987.2008.00586.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
99 Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Malago M, Klammt S, Loehr M, Liebe S, Mitzner S, Schmidt R, Stange J. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002;36:949-58. [PMID: 12297843 DOI: 10.1053/jhep.2002.36130] [Cited by in Crossref: 284] [Cited by in F6Publishing: 226] [Article Influence: 14.9] [Reference Citation Analysis]
100 Borberg H. Quo vadis haemapheresis. Current developments in haemapheresis. Transfus Apher Sci 2006;34:51-73. [PMID: 16412691 DOI: 10.1016/j.transci.2005.11.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
101 Jung A, Krisper P, Haditsch B, Stauber RE, Trauner M, Holzer H, Schneditz D. Bilirubin Kinetic Modeling for Quantification of Extracorporeal Liver Support. Blood Purif 2006;24:413-22. [DOI: 10.1159/000094575] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
102 Chan C, Berthiaume F, Nath BD, Tilles AW, Toner M, Yarmush ML. Hepatic tissue engineering for adjunct and temporary liver support: Critical technologies. Liver Transpl 2004;10:1331-42. [DOI: 10.1002/lt.20229] [Cited by in Crossref: 97] [Cited by in F6Publishing: 81] [Article Influence: 5.7] [Reference Citation Analysis]
103 Rifai K, Tetta C, Ronco C. Prometheus: From Legend to the Real Liver Support Therapy. Int J Artif Organs 2007;30:858-63. [DOI: 10.1177/039139880703001002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
104 Court FG, Wemyss-Holden SA, Dennison AR, Maddern GJ. Bioartificial liver support devices: historical perspectives. ANZ J Surg. 2003;73:739-748. [PMID: 12956791 DOI: 10.1046/j.1445-2197.2003.02741.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
105 Roth GA, Nickl S, Lebherz-Eichinger D, Schmidt EM, Ankersmit HJ, Faybik P, Hetz H, Krenn CG. Lipocalin-2 serum levels are increased in acute hepatic failure. Transplant Proc 2013;45:241-4. [PMID: 23375308 DOI: 10.1016/j.transproceed.2012.02.047] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
106 Herrera gutiérrez M, Seller G, Muñoz A, Lebrón M, Aragón C. Soporte hepático extracorpóreo: situación actual y expectativas de futuro. Medicina Intensiva 2004;28:211-8. [DOI: 10.1016/s0210-5691(04)70048-0] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
107 van de Kerkhove MP, Hoekstra R, Chamuleau RA, van Gulik TM. Clinical application of bioartificial liver support systems. Ann Surg 2004;240:216-30. [PMID: 15273544 DOI: 10.1097/01.sla.0000132986.75257.19] [Cited by in Crossref: 137] [Cited by in F6Publishing: 111] [Article Influence: 8.1] [Reference Citation Analysis]
108 Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: Summary of a workshop. Hepatology. 2008;47:1401-1415. [PMID: 18318440 DOI: 10.1002/hep.22177] [Cited by in Crossref: 442] [Cited by in F6Publishing: 388] [Article Influence: 34.0] [Reference Citation Analysis]
109 Roth GA, Faybik P, Hetz H, Ankersmit HJ, Hoetzenecker K, Bacher A, Thalhammer T, Krenn CG. MCP-1 and MIP3-alpha serum levels in acute liver failure and molecular adsorbent recirculating system (MARS) treatment: a pilot study. Scand J Gastroenterol. 2009;44:745-751. [PMID: 19247846 DOI: 10.1080/00365520902770086] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
110 Collins KL, Roberts EA, Adeli K, Bohn D, Harvey EA. Single pass albumin dialysis (SPAD) in fulminant Wilsonian liver failure: a case report. Pediatr Nephrol. 2008;23:1013-1016. [PMID: 18299897 DOI: 10.1007/s00467-008-0761-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
111 Rifai K, Ernst T, Kretschmer U, Hafer C, Haller H, Manns MP, Fliser D. The Prometheus device for extracorporeal support of combined liver and renal failure. Blood Purif 2005;23:298-302. [PMID: 15980619 DOI: 10.1159/000086552] [Cited by in Crossref: 54] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
112 Faybik P, Hetz H, Baker A, Bittermann C, Berlakovich G, Werba A, Krenn C, Steltzer H. Extracorporeal albumin dialysis in patients with Amanita phalloides poisoning: Extracorporeal albumin dialysis in patients with Amanita phalloides poisoning. Liver International 2003;23:28-33. [DOI: 10.1034/j.1478-3231.23.s.3.8.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
113 Chamuleau RA, Poyck PP, van de Kerkhove MP. Bioartificial liver: its pros and cons. Ther Apher Dial. 2006;10:168-174. [PMID: 16684219 DOI: 10.1111/j.1744-9987.2006.00359.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
114 Di Campli C, Gasbarrini G, Gasbarrini A. Review article: a medicine based on cell transplantation - is there a future for treating liver diseases?: REVIEW: CELL TRANSPLANTATION AND LIVER DISEASE. Alimentary Pharmacology & Therapeutics 2003;18:473-80. [DOI: 10.1046/j.1365-2036.2003.01692.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
115 Patzer JF, Bane SE. Bound Solute Dialysis. ASAIO Journal 2003;49:271-81. [DOI: 10.1097/01.mat.0000065378.73558.83] [Cited by in Crossref: 27] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
116 Laleman W, Wilmer A, Evenepoel P, Elst IV, Zeegers M, Zaman Z, Verslype C, Fevery J, Nevens F. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care. 2006;10:R108. [PMID: 16859530 DOI: 10.1186/cc4985] [Cited by in Crossref: 174] [Cited by in F6Publishing: 143] [Article Influence: 11.6] [Reference Citation Analysis]
117 Punch JD. Bridges to transplantation. Anesthesiol Clin North Am 2004;22:863-9. [PMID: 15541939 DOI: 10.1016/j.atc.2004.05.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
118 Klammt S, Stange J, Mitzner SR, Peszynski P, Peters E, Liebe S. Extracorporeal liver support by recirculating albumin dialysis: analysing the effect of the first clinically used generation of the MARSystem. Liver 2002;22 Suppl 2:30-4. [PMID: 12220300 DOI: 10.1034/j.1600-0676.2002.00005.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
119 Wang S, Nagrath D. Liver Tissue Engineering. In: Burdick JA, Mauck RL, editors. Biomaterials for Tissue Engineering Applications. Vienna: Springer; 2011. pp. 389-419. [DOI: 10.1007/978-3-7091-0385-2_14] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
120 Brown RS. MARS preconditioning for living donor liver transplantation: panacea or placebo? Liver Int 2005;25:692-5. [DOI: 10.1111/j.1478-3231.2005.01133.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
121 Rittler P, Ketscher C, Inthorn D, Jauch KW, Hartl WH. Use of the molecular adsorbent recycling system in the treatment of postoperative hepatic failure and septic multiple organ dysfunction--preliminary results. Liver Int. 2004;24:136-141. [PMID: 15078478 DOI: 10.1111/j.1478-3231.2004.0898.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
122 Wang Z, Cao Y, Wei H, Jia L, Xu L, Xie J. Bilirubin adsorption properties of water-soluble adsorbents with different cyclodextrin cavities in plasma dialysis system. Colloids and Surfaces B: Biointerfaces 2012;90:248-53. [DOI: 10.1016/j.colsurfb.2011.10.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
123 Betrosian AP, Agarwal B, Douzinas EE. Acute renal dysfunction in liver diseases. World J Gastroenterol 2007; 13(42): 5552-5559 [PMID: 17948928 DOI: 10.3748/wjg.v13.i42.5552] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 55] [Article Influence: 5.0] [Reference Citation Analysis]
124 Carpentier B, Ash SR. Sorbent-based artificial liver devices: principles of operation, chemical effects and clinical results. Expert Rev Med Devices 2007;4:839-61. [PMID: 18035950 DOI: 10.1586/17434440.4.6.839] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
125 Arroyo V, Colmenero J. Use of albumin in the management of patients with decompensated cirrhosis. Digestive and Liver Disease 2003;35:668-72. [DOI: 10.1016/s1590-8658(03)00383-9] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
126 Yonekawa C, Nakae H, Tajimi K, Asanuma Y. Effectiveness of combining plasma exchange and continuous hemodiafiltration in patients with postoperative liver failure. Artif Organs. 2005;29:324-328. [PMID: 15787627 DOI: 10.1111/j.1525-1594.2005.29054.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
127 Bergasa NV. Treatment of the pruritus of cholestasis. Curr Treat Options Gastro 2004;7:501-8. [DOI: 10.1007/s11938-004-0009-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
128 Brophy CM, Nyberg SL. Extracorporeal treatment of acute liver failure. Hepatol Res 2008;38 Suppl 1:S34-40. [PMID: 19125950 DOI: 10.1111/j.1872-034X.2008.00424.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
129 Miyazawa M, Torii T, Toshimitsu Y, Koyama I. Effect of Mechanical Stress Imposition on Co-culture of Hepatic Parenchymal and Nonparenchymal Cells: Possibility of Stimulating Production of Regenerating Factor. Transplantation Proceedings 2005;37:2398-401. [DOI: 10.1016/j.transproceed.2005.03.103] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
130 Ronco C, Tetta C. Extracorporal blood purification: more than diffusion and convection. Does this help?: . Current Opinion in Critical Care 2007;13:662-7. [DOI: 10.1097/mcc.0b013e3282f194c0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
131 Sauer IM, Goetz M, Steffen I, Walter G, Kehr DC, Schwartlander R, Hwang YJ, Pascher A, Gerlach JC, Neuhaus P. In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD). Hepatology 2004;39:1408-14. [PMID: 15122770 DOI: 10.1002/hep.20195] [Cited by in Crossref: 118] [Cited by in F6Publishing: 77] [Article Influence: 6.9] [Reference Citation Analysis]
132 De Simone P, Van Nuffelen M, Donckier V. Use of molecular adsorbent recirculating system for treatment of refractory pruritus. Liver Transpl 2003;9:997-8. [DOI: 10.1002/lt.500090918] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
133 Arokianathan D, Trower K, Pooboni S, Sosnowski A, Moss P, Thaker H. Leptospirosis: a case report of a patient with pulmonary haemorrhage successfully managed with extra corporeal membrane oxygenation. Journal of Infection 2005;50:158-62. [DOI: 10.1016/j.jinf.2004.09.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
134 Barshes NR, Gay AN, Williams B, Patel AJ, Awad SS. Support for the Acutely Failing Liver: A Comprehensive Review of Historic and Contemporary Strategies. Journal of the American College of Surgeons 2005;201:458-76. [DOI: 10.1016/j.jamcollsurg.2005.04.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]